Omega-3 fatty acids linked to lower myopia risk in children, Hong Kong study finds
By
FollowingTheDao
Crackling crust, pillowy middle. The kind of bagel that earns a second cup of coffee.
Summary
A population-based study of 1,005 Chinese children aged 6-8 years from the Hong Kong Children Eye Study found that dietary intake of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) is a protective factor against myopia development. Children with the highest ω-3 PUFA intake had shorter axial lengths and more positive spherical equivalent refractions compared to those with the lowest intake. Conversely, higher intake of saturated fatty acids (SFA) was associated with longer axial length, indicating a risk factor for myopia. The associations remained significant after adjusting for age, sex, BMI, near-work time, outdoor time, and parental myopia history. No other dietary nutrients showed significant associations with myopia.
Key quotes
· 5 pulledAL was longest in the lowest quartile group of ω-3 PUFAs intake, compared with the highest (adjusted mean (95% CI), 23.29 (23.17 to 23.40) mm vs 23.08 (22.96 to 23.19) mm, p=0.01; p-trend=0.02)
AL was longest in the highest quartile group of saturated fatty acids (SFA) intake, compared with the lowest (23.30 (23.17 to 23.42) mm vs 23.13 (23.01 to 23.24) mm, p=0.05; p-trend=0.04)
A lower intake of ω-3 PUFAs was associated with myopia (p-trend=0.006)
Intake of ω-3 PUFAs is a protective factor against myopia, while higher SFA intake is a risk factor.
Our findings indicated a possible effect of diet on myopia, of which ω-3 PUFAs intake may play a protective role against myopia development in children.
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
